- 2
- 0
- 约2.62千字
- 约 2页
- 2023-12-11 发布于上海
- 举报
丹参PPAR-α受体激动效应的体外研究的开题报告
Title:InvitrostudyofPPAR-αreceptoractivationeffectofSalviamiltiorrhiza
Introduction:
Salviamiltiorrhiza,alsoknownasDanshen,hasbeenusedintraditionalChinesemedicineforcenturiesasaremedyforvariousdiseases.Itcontainsmanyactivecompounds,includingtanshinonesandsalvianolicacids,thathavebeenfoundtopossessmultiplepharmacologicalproperties,suchasantioxidant,anti-inflammatory,andcardiovascularprotectiveeffects.RecentstudieshavealsodemonstratedthatDanshenhasthepotentialtoactivateperoxisomeproliferator-activatedreceptoralpha(PPAR-α),atranscriptionalfactorinvolvedinlipidmetabolismandinflammation.Therefore,thisstudyaimstoinvestigatethePPAR-αreceptoractivationeffectofDansheninvitro.
Methodology:
1.Cellculture:Humanhepatomacells(HepG2)willbeculturedinDulbeccosModifiedEaglesMedium(DMEM)supplementedwith10%fetalbovineserum,1%penicillin-streptomycin,and1%L-glutamineinahumidifiedincubatorat37℃with5%CO2.
2.Experimentalgroups:HepG2cellswillbedividedintofourgroups:controlgroup,PPAR-αagonistgroup,low-doseDanshengroup,andhigh-doseDanshengroup.
3.Treatment:Cellsinthecontrolgroupwillreceivenotreatment,whilecellsinthePPAR-αagonistgroupwillbetreatedwith10μMofWy14643,aselectivePPAR-αagonist.Cellsinthelow-doseDanshengroupandhigh-doseDanshengroupwillbetreatedwith50μg/mLand100μg/mLofDanshenextract,respectively.
4.MeasurementofPPAR-αactivity:TherelativePPAR-αactivitywillbeassessedusingtheDual-LuciferaseReporterAssaySystem.ThePPAR-αresponsiveelement(PPRE)plasmidandRenillaluciferaseplasmidwillbeco-transfectedintoHepG2cellswithLipofectamine2000,followedbytreatmentwiththerespectiveexperimentalgroup.
5.Dataanalysis:Thedatawillbeanalyzedusingone-wayANOVAfollowedbyTukeysposthoctest.
ExpectedResults:
Weexpecttoobserve
您可能关注的文档
最近下载
- ISO IEC 42001 人工智能管理体系白皮书——AI风险治理.docx
- ISO_IEC 42001_2023 人工智能管理体系要求培训课件.pptx VIP
- ISO IEC42001-2023人工智能管理体系培训教材.pptx
- ISO∕IEC 42001-2023《信息技术-人工智能-管理体系》之5:“5领导作用-5.2 人工智能方针”解读和应用指导材料(雷泽佳编制-2024A0).docx VIP
- ISO∕IEC 42001-2023《信息技术-人工智能-管理体系》之13:“7支持-7.5成文信息”解读和应用指导材料(雷泽佳编制-2024A0).docx VIP
- ISO∕IEC 42001-2023《信息技术-人工智能-管理体系》之8:“6策划-6.3 变更的策划”解读和应用指导材料(雷泽佳编制-2024A0).docx VIP
- ISO∕IEC 42001-2023《信息技术-人工智能-管理体系》之16:“10改进”解读和应用指导材料(雷泽佳编制-2024A0).docx VIP
- ISO∕IEC 42001-2023《信息技术-人工智能-管理体系》之10:“7支持-7.2能力”解读和应用指导材料(雷泽佳编制-2024A0).docx VIP
- ISO∕IEC 42001-2023《信息技术-人工智能-管理体系》之17:“8 运行”解读和应用指导材料(雷泽佳编制-2024A0).docx VIP
- 《ISO∕IEC42024-2025信息技术-人工智能-管理体系》解读和应用指导材料(雷泽佳2024A0).pptx VIP
原创力文档

文档评论(0)